Methodological concerns in the cutoff determination of a flow cytometric MOG-IgG assay: The need for independent validation
Su-Hyun Kim(National Cancer Center), Ho Jin Kim(National Cancer Center), Fabienne Brilot(The University of Sydney), Ju‐Hong Min(Samsung (South Korea)), Sean Pittock(Mayo Clinic)
Cited by 0
Related Papers
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
Tonsilar NK Cells Restrict B Cell Transformation by the Epstein-Barr Virus via IFN-γ
|PLoS Pathogens|2008|124
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82